跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,081 条关于
“TAD-SIE”
全部
11,081
临床试验
9,467
药物
808
机构
109
资讯
697
去年
Novel TAD-SIE Algorithm Shows Promise in Optimizing Clinical Trial Sample Sizes
上个月
Sprint-interval exercise triggers a distinct molecular surge linked to cardiometabolic health
去年
Study Evaluates Diagnostic Accuracy of Sentinel Lymph Node Biopsy and Wire Localized Clipped Node in Breast Cancer Patients
9个月前
Less Invasive Axillary Staging Procedures Show Noninferiority to Standard Lymph Node Dissection in Breast Cancer
2个月前
Intraoperative Frozen Section Analysis After Neoadjuvant Chemotherapy Leads to Unnecessary ALND in Node-Negative Breast Cancer Patients
去年
Alpha Tau Receives FDA TAP Acceptance to Expedite Alpha DaRT for Recurrent Glioblastoma
2年前
IAG933, a Novel YAP/TAZ-TEAD Inhibitor, Shows Promise in Preclinical Cancer Models
去年
Athira Pharma Presents LIFT-AD Trial Results for Fosgonimeton at CTAD 2024
去年
Relay Therapeutics' RLY-2608: A Mutant-Selective PI3Kα Inhibitor Enters Phase I Trials for HR+/HER2- Breast Cancer
去年
Oncolytic Virus Ad-TD-nsIL12 Shows Promise in Glioblastoma Phase I Trial
第 1 页,共 70 页
上一页
下一页